Vascular endothelial growth factor protects spinal cord motoneurons against glutamate-induced excitotoxicity via phosphatidylinositol 3-kinase.
about
Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorderTrophic factors as modulators of motor neuron physiology and survival: implications for ALS therapyLead exposure stimulates VEGF expression in the spinal cord and extends survival in a mouse model of ALSAberrant regulation of DNA methylation in amyotrophic lateral sclerosis: a new target of disease mechanisms.Roles of vascular endothelial growth factor in amyotrophic lateral sclerosis.Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration.Phosphatase and tensin homologue/protein kinase B pathway linked to motor neuron survival in human superoxide dismutase 1-related amyotrophic lateral sclerosis.Multiple neurotrophic effects of VEGF on cultured neurons.Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand?VEGF-A165b is cytoprotective and antiangiogenic in the retinaNeuroprotection using gene therapy to induce vascular endothelial growth factor-A expressionMotor neuron trophic factors: therapeutic use in ALS?Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disordersSpinal vascular endothelial growth factor induces phrenic motor facilitation via extracellular signal-regulated kinase and Akt signaling.Hypoxia induces angiogenic factors in brain microvascular endothelial cells.Regulation of nuclear TDP-43 by NR2A-containing NMDA receptors and PTEN.Recent advances in amyotrophic lateral sclerosis research: perspectives for personalized clinical applicationExtraocular motoneurons of the adult rat show higher levels of vascular endothelial growth factor and its receptor Flk-1 than other cranial motoneurons.Cellular connections, microenvironment and brain angiogenesis in diabetes: Lost communication signals in the post-stroke period.VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma.Mutant copper-zinc superoxide dismutase associated with amyotrophic lateral sclerosis binds to adenine/uridine-rich stability elements in the vascular endothelial growth factor 3'-untranslated region.Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease.Genetic studies of amyotrophic lateral sclerosis: controversies and perspectives.Guidance from above: common cues direct distinct signaling outcomes in vascular and neural patterning.Neurotrophic modulation of motor neuron development.Stem cells: comprehensive treatments for amyotrophic lateral sclerosis in conjunction with growth factor delivery.Implications of vascular endothelial growth factor for postischemic neurovascular remodeling.Survivin: a target from brain cancer to neurodegenerative disease.Brief review of the role of glycogen synthase kinase-3β in amyotrophic lateral sclerosis.Effects of vascular endothelial growth factor in ischemic stroke.VEGF ligands and receptors: implications in neurodevelopment and neurodegeneration.Efficient gene expression from integration-deficient lentiviral vectors in the spinal cord.Selective vulnerability of motoneuron and perturbed mitochondrial calcium homeostasis in amyotrophic lateral sclerosis: implications for motoneurons specific calcium dysregulation.Organotypic Spinal Cord Culture: a Proper Platform for the Functional Screening.Role of VEGF and VEGFR2 Receptor in Reversal of ALS-CSF Induced Degeneration of NSC-34 Motor Neuron Cell Line.Vascular endothelial growth factor attenuates neurodegenerative changes in the NSC-34 motor neuron cell line induced by cerebrospinal fluid of sporadic amyotrophic lateral sclerosis patients.Experimental models for the study of neurodegeneration in amyotrophic lateral sclerosis.Astrocytes in amyotrophic lateral sclerosis: direct effects on motor neuron survival.Cellular and molecular mechanisms involved in the neuroprotective effects of VEGF on motoneurons.Delayed administration of VEGF rescues spinal motor neurons from death with a short effective time frame in excitotoxic experimental models in vivo.
P2860
Q24626017-0F6BEA18-D1D9-4B60-95B0-2BC8EA21A714Q26999881-41C6815D-3A97-4D1D-9764-CFABA99F47E1Q28393678-B067949E-C257-4D07-A1A6-F9E64526C7E7Q30552760-6194878B-B419-41F3-ABE0-6DB4E50AD958Q33616384-60A7DF3B-79E2-4649-803D-61A2D673AE77Q33782744-2345BAEC-656D-442B-BB85-648501F917E4Q33791649-E2A61D0F-7631-480B-9B25-D401E8D9F5E6Q33888914-64CBF3A5-54C2-4179-AF0F-DDA5312E3608Q33985590-4919C61B-3A8F-4431-A934-4A704F0BB907Q34022623-5A54464B-D6BB-4A94-A556-F96AA7912D8EQ34430669-3E438AA5-1A0F-48DF-8235-A6919AFFF49EQ35027903-43382091-D366-428F-A32B-AD76A6718537Q35197096-5D021EA7-3948-47A6-B99F-784ED5A359B0Q35212423-AA525EE6-DB9F-468A-BAE7-EB9A2F9A1735Q35754099-70A90301-A827-430B-B4E1-7B918842D017Q35912453-31195082-645A-48DD-B7D1-2EBF2BAF5D31Q36117618-68185847-4525-4623-8879-FA3D194DE82CQ36389531-70F148FE-F277-4CF6-9DB8-6E56C33325F4Q36551157-D086DBBB-EFD5-4F77-8A7C-5802B72FE8B2Q36715908-139FAA7A-D3E7-41C3-8A3E-2B03AB6D0604Q37107632-E060DCD5-6DDF-4D9A-86D2-E58686F5768BQ37216153-864BB52E-6477-413A-A32D-6E0491F1846AQ37358932-E8152E08-D232-4CFC-A04A-6FB2915AFC13Q37387884-FE6973B4-638D-4694-8C2D-D2EC8F5BE314Q37393565-B518AC30-86FB-493A-95E4-8F8669FBDEA1Q37417183-3E938BA1-DF84-401A-90A1-B99EB0E431C1Q37572370-15A98DD4-67A8-4D3D-91EE-418DA59ABE6AQ37798272-DE8267DF-B51F-423C-A991-D6929323D198Q37878260-F85290E6-62F4-4B5C-8704-DA46CA1C567AQ38020128-69616A3B-7F76-4A2F-AF70-9BD9CFE6EF42Q38087877-0E6719B4-1848-4B3D-83AD-2AB3E816D31DQ38457292-E2CBCA90-9645-4245-836A-3666E5517159Q38521756-CC1F9A7E-548C-4DA6-B40F-CAC1AA73C737Q38574564-98DCDE6C-6596-465C-9DE7-9D6D31D64236Q38989728-D1F7C453-4670-41B8-91FC-5214AA661D8CQ39578531-E591CFF7-1AB9-4436-93A7-E567576B67D5Q39823079-77A8F916-D97B-4926-987D-C9E98BB5E5EDQ41874406-3286DCB4-DAFD-4CF2-B59A-EFA44A8F26D8Q42044273-5E53EFD5-DD64-4629-A009-5D33878B41BBQ42563652-37BE8549-C58D-470A-9CFC-7D6958A3B44B
P2860
Vascular endothelial growth factor protects spinal cord motoneurons against glutamate-induced excitotoxicity via phosphatidylinositol 3-kinase.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Vascular endothelial growth fa ...... phosphatidylinositol 3-kinase.
@en
Vascular endothelial growth fa ...... phosphatidylinositol 3-kinase.
@nl
type
label
Vascular endothelial growth fa ...... phosphatidylinositol 3-kinase.
@en
Vascular endothelial growth fa ...... phosphatidylinositol 3-kinase.
@nl
prefLabel
Vascular endothelial growth fa ...... phosphatidylinositol 3-kinase.
@en
Vascular endothelial growth fa ...... phosphatidylinositol 3-kinase.
@nl
P2093
P2860
P1476
Vascular endothelial growth fa ...... phosphatidylinositol 3-kinase
@en
P2093
Jerònia Lladó
Margalida Mir
Víctor J Asensio
P2860
P304
P356
10.1111/J.1471-4159.2007.05206.X
P407
P577
2007-12-25T00:00:00Z